Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5.32 AUD | +1.14% | +0.57% | -7.96% |
May. 16 | Atlas Arteria Appoints Auditor | MT |
May. 16 | Transcript : Atlas Arteria Limited - Shareholder/Analyst Call |
Sales 2024 * | 257M 171M | Sales 2025 * | 276M 184M | Capitalization | 7.72B 5.13B |
---|---|---|---|---|---|
Net income 2024 * | 525M 349M | Net income 2025 * | 519M 345M | EV / Sales 2024 * | 35.2 x |
Net Debt 2024 * | 1.34B 891M | Net Debt 2025 * | 1.42B 946M | EV / Sales 2025 * | 33.1 x |
P/E ratio 2024 * |
18
x | P/E ratio 2025 * |
16.8
x | Employees | - |
Yield 2024 * |
7.54% | Yield 2025 * |
7.55% | Free-Float | 72.14% |
Latest transcript on Atlas Arteria Limited
1 day | +1.14% | ||
1 week | +0.57% | ||
1 month | +1.72% | ||
3 months | -0.93% | ||
6 months | -6.50% | ||
Current year | -7.96% |
Managers | Title | Age | Since |
---|---|---|---|
Graeme Bevans
CEO | Chief Executive Officer | 66 | 18-04-30 |
David Collins
DFI | Director of Finance/CFO | - | 22-08-29 |
Chief Operating Officer | 41 | 18-11-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 63 | 18-09-30 | |
Director/Board Member | 77 | 18-10-31 | |
Laura Hendricks
BRD | Director/Board Member | - | 23-10-15 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.68% | 120 M€ | +1.02% | - | |
0.25% | 75 M€ | +7.28% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-31 | 5.32 | +1.14% | 3,820,420 |
24-05-30 | 5.26 | -.--% | 1,847,571 |
24-05-29 | 5.26 | -0.94% | 1,344,250 |
24-05-28 | 5.31 | -1.48% | 1,733,346 |
24-05-27 | 5.39 | +1.89% | 1,302,050 |
Delayed Quote Australian S.E., May 31, 2024 at 02:10 am EDT
More quotesEPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-7.96% | 5.12B | |
-8.75% | 25.68B | |
+0.22% | 20.21B | |
+20.27% | 11.07B | |
+15.81% | 7.46B | |
+6.75% | 6.78B | |
+5.41% | 6.54B | |
+27.38% | 5.91B | |
+1.39% | 4.54B | |
-15.09% | 4.63B |
- Stock Market
- Equities
- ALX Stock